2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Sunday, December 13, 2026
12:00 p.m. - 01:30 p.m.
MCCNO - 291-292
Technology and Procedures, Assays, Imaging, Molecular Testing, Omics Technologies, Pathology, Bioinformatics, Gene Editing, Profiling, Treatment Considerations, Drug Development, Biological Therapies, Gene Therapy, Biological Processes, Pathogenesis, CHIP, Genomics, Hematopoiesis, Molecular Biology, Diseases, Bone Marrow Failure Syndromes, Inherited Marrow Failure Syndromes, Aplastic Anemia, Genetic Disorders, Research, Fundamental Science, Translational Research, Study Population, Human, Animal Model
PAPER

589 The integrator complex coordinates enhancer activity and RNA polymerase II pausing during terminal erythroid maturation

Deanna M Abid, Lovely Soni, MS2, Kristin Murphy3, Nabil Fazleh Rahman, MS4, Michael Getman5, Kathleen E McGrath, PhD6, Eric Wagner7, Laurie A Steiner, MD8
1 University of Rochester, Rochester, New York, United States
2 University of Rochester, Rochester, New York, United States
3 University of Rochester, Rochester, New York, United States
4 University of Rochester, Rochester, New York, United States
5 University of Rochester, Rochester, New York, United States
6 University of Rochester, Rochester, New York, United States
7 University of Rochester, University of Rochester, United States
8 University of Rochester, Rochester, New York, United States

Terminal erythroid maturation requires extensive transcriptional remodeling as proliferating erythroblasts progressively silence genes no longer required while maintaining high-level expression of genes essential for red blood cell function. This transition is accompanied by a global decline in RNA polymerase II (RNAPII), increased promoter-proximal pausing at many genes, and selective maintenance of productive transcription at key erythroid loci. Stage-specific enhancers coordinate the timing and magnitude of erythroid gene expression throughout this process. The Integrator complex is a multi-subunit RNAPII-associated complex composed of distinct structural and catalytic modules. Integrator is best known for attenuating transcription through promoter-proximal termination at protein-coding genes (Elrod et al., Molecular Cell, 2019). More recently, Integrator has been implicated in enhancer regulation through processing of enhancer RNAs (eRNAs) and enhancer-promoter communication (Lai et al., Nature, 2015), with additional evidence supporting a role at the β-globin locus control region (LCR) (Gurumurthy et al., Nucleic Acids Research, 2021). However, its function during erythropoiesis remains incompletely understood.

            We hypothesized that Integrator coordinates both promoter-proximal RNAPII pausing and enhancer activity during erythropoiesis. To test this hypothesis, we profiled INTS1, INTS8, and INTS9 occupancy by CUT&RUN in basophilic and orthochromatic erythroblasts differentiated from primary human CD34? hematopoietic stem and progenitor cells (n = 3 biological replicates per stage). All three Integrator subunits exhibited extensive co-occupancy at promoters, with promoter enrichment increasing during erythroid maturation. Integrator occupancy correlated with increased promoter-proximal RNAPII pausing and decreased gene-body Ser2-phosphorylated RNAPII, consistent with a role in regulating productive transcriptional elongation.

            To define the enhancer landscape, we performed CUT&Tag for H3K4me1 and H3K27ac in basophilic and orthochromatic erythroblasts (n = 3 biological replicates per stage). Distal H3K4me1-marked regions were classified as primed when lacking H3K27ac and active when co-occupied by H3K27ac, while regions within 2 kb of transcription start sites were excluded to distinguish enhancer from promoter occupancy. Super-enhancers were identified using ROSE rank ordering of H3K27ac signal. At both stages, all three Integrator subunits showed significantly greater occupancy at active than primed distal enhancers (Wilcoxon rank-sum test, P < 0.0001). Enhancers that remained active throughout differentiation were more than threefold more likely to be occupied by INTS1 than enhancers activated only at the orthochromatic stage (30.4% vs. 9.2%; χ² test, P < 0.0001), indicating preferential localization to stable lineage-defining regulatory elements. Likewise, super-enhancers were enriched for Integrator occupancy, with INTS1 detected 2.8- and 2.7-fold more frequently at super-enhancers than typical enhancers in basophilic and orthochromatic erythroblasts (χ² test, P < 0.0001 for both stages); INTS8 and INTS9 exhibited similar patterns. Prominent Integrator-bound super-enhancers included the β-globin LCR, the α-globin regulatory domain, and the erythroid BCL11A enhancer.

            To determine the functional importance of Integrator, we generated CRISPR-edited HUDEP2 cell lines with reduced INTS1 expression. Despite extensive screening, no complete INTS1 knockout clones were recovered, suggesting that INTS1 is essential for erythroid cell survival. INTS1-deficient cells exhibited delayed erythroid maturation and reduced α- and β-globin expression, supporting an essential role for Integrator in terminal erythroid differentiation and the regulation of globin gene expression.

            Together, these studies identify Integrator as a previously unrecognized regulator of erythroid transcriptional remodeling. Integrator preferentially localizes to promoters with paused RNAPII and to active erythroid enhancers, particularly stable lineage-defining enhancers and super-enhancers. These findings support a model in which Integrator coordinates promoter-proximal transcriptional control with enhancer activity to establish and maintain the erythroid transcriptional program during terminal maturation.

Deanna M Abid: No relevant conflicts of interest to declare.